Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/16/2014 | CN102973538B 一种巴布剂基质及其应用 One kind of poultice matrix and its application |
07/16/2014 | CN102908441B 一种用于止痛的微乳型药物组合物凝胶膏剂及其制备方法 Microemulsion pharmaceutical composition and method for preparing a gel ointment for pain |
07/16/2014 | CN102885777B 氟苯尼考粉剂组合物及其制备方法 Florfenicol powder composition and preparation method |
07/16/2014 | CN102871961B 一种含替罗非班的注射液 Containing tirofiban Injection |
07/16/2014 | CN102784105B Rlt多肽介导的多西紫杉醇肿瘤靶向亚微乳剂及其制备方法 Rlt polypeptide-mediated tumor targeting docetaxel submicron emulsion and its preparation method |
07/16/2014 | CN102746474B 一种温度和pH敏感性的壳交联聚合物胶束的制备方法 A temperature and pH-sensitive shell cross-linked polymer micelle preparation |
07/16/2014 | CN102716090B 一种盐酸二甲双胍缓释微丸及其制备方法 One kind of metformin hydrochloride sustained-release pellets and its preparation method |
07/16/2014 | CN102697723B 一种甲基斑蝥胺脂肪乳剂及其制备方法 A solution of methyl amine cantharidin fat emulsion and its preparation method |
07/16/2014 | CN102525990B 一种艾普拉唑肠溶片剂及其制备方法 One kind ilaprazole enteric tablet and its preparation method |
07/16/2014 | CN102512692B 肿瘤靶向栓塞治疗组合物及其制备方法 Targeting tumor embolization composition and preparation method |
07/16/2014 | CN102397284B 一种螺旋霉素的口服组合物及其制备方法 One kind of spiramycin oral composition and preparation method |
07/16/2014 | CN102357080B 一种酸性环境中可实现药物快速释放的智能型多功能空心微球及其制备方法 An acidic environment can be achieved Intelligent Multifunctional hollow microspheres and drug preparation quick release |
07/16/2014 | CN102349939B 雪莲提取物微乳剂组合物 Lotus extract microemulsion composition |
07/16/2014 | CN102300588B 低聚物-吩噻嗪缀合物 Oligomer - phenothiazine conjugate |
07/16/2014 | CN102048725B 紫杉醇胆固醇复合物 Taxol cholesterol complexes |
07/16/2014 | CN101932311B 微粒及其药物组合物 Particles and pharmaceutical compositions thereof |
07/16/2014 | CN101795558B 含有n-取代的氨基磺酸缓冲剂的体液增容剂 Substituted amino group-containing sulfonic acid buffer n- humoral compatibilizer |
07/16/2014 | CN101766631B 注射用前列地尔组合物 Alprostadil injection compositions |
07/16/2014 | CN101678123B 包含疏水性化合物和聚氨基酸结合物的组合物 The composition comprising a hydrophobic compound and a polyamino acid conjugates |
07/16/2014 | CN101674810B 针对癌细胞和癌相关成纤维细胞的靶向剂 For cancer cells and cancer-associated fibroblasts targeting agent |
07/16/2014 | CN101455650B 经皮吸收贴剂及制造方法 Transdermal absorption patch and method of manufacture |
07/16/2014 | CN101166543B 含抗痴呆药物的组合物 Compositions containing anti-dementia drugs |
07/15/2014 | US8779114 siRNA conjugate and preparation method thereof |
07/15/2014 | US8779089 Methods and compositions for soft tissue repair |
07/15/2014 | US8779010 Water-in-oil emulsified cosmetic |
07/15/2014 | US8779009 Fiber containing compositions and methods of making and using same |
07/15/2014 | US8779008 Polymeric micelles for drug delivery |
07/15/2014 | US8779007 Preparation containing diol |
07/15/2014 | US8779006 Compositions and methods for treatment and prevention of osteoarthritis |
07/15/2014 | US8779004 Stable emulsion formulations |
07/15/2014 | US8779000 Saccharide free, storage stable thyroid hormone active drug formulations and methods for their production |
07/15/2014 | US8778999 Non-steroidal anti-inflammatory ophthalmic compositions |
07/15/2014 | US8778987 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste |
07/15/2014 | US8778914 Bisphosphonate-prodrugs |
07/15/2014 | US8778886 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
07/15/2014 | US8778880 Human growth hormone modified at position 35 |
07/15/2014 | US8778684 Herpes simplex virus complex |
07/15/2014 | US8778400 Nanoparticle-stabilized capsule formulation for treatment of inflammation |
07/15/2014 | US8778390 Orally effective methylphenidate extended release powder and aqueous suspension product |
07/15/2014 | US8778377 Drug implant carrier for drug delivery |
07/15/2014 | US8778369 Barrier film-forming compositions and methods of use |
07/15/2014 | US8778365 Topical compositions and methods for making and using same |
07/15/2014 | US8778336 Stabilized proteases that have been immobilized and further crosslinked for use in skin care |
07/15/2014 | US8778325 Water-soluble and biodegradable antimicrobial agent |
07/15/2014 | US8778324 Ion binding polymers and uses thereof |
07/15/2014 | US8778322 pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
07/15/2014 | US8778319 Polysiloxanes having quaternary ammonium groups, method for producing same and use thereof in formulations for cleansing and care |
07/15/2014 | US8778306 Colon lavage system |
07/15/2014 | US8778301 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
07/15/2014 | CA2782510C Polypeptides |
07/15/2014 | CA2647455C Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein |
07/15/2014 | CA2636599C Modified macromolecule |
07/15/2014 | CA2611077C Dental mineralization |
07/15/2014 | CA2526398C Human monoclonal antibodies against bacillus anthracis protective antigen |
07/10/2014 | WO2014107596A1 Compositions and methods for polynucleotide transfection |
07/10/2014 | WO2014107572A1 Body surface treatment composition and method |
07/10/2014 | WO2014107419A1 Use of oscillating gradients of high magnetic field for specific destruction of cells labeled with magnetic nanoparticles |
07/10/2014 | WO2014107200A1 Polymer-drug systems |
07/10/2014 | WO2014107024A1 Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same |
07/10/2014 | WO2014106962A1 Novel fast-dissolving granule formulation having improved solubility |
07/10/2014 | WO2014106943A1 Medicinal composition containing docetaxel |
07/10/2014 | WO2014106649A1 Selective nox-1 inhibitor peptides and uses thereof |
07/10/2014 | WO2014106541A1 Dermal composition for use in the external genital area in females |
07/10/2014 | WO2014056722A3 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
07/10/2014 | US20140194651 Off-note blocking sensory organic compounds |
07/10/2014 | US20140194601 Antibody drug conjugates (adc) that bind to 161p2f10b proteins |
07/10/2014 | US20140194598 B7-related nucleic acids and polypeptides useful for immunomodulation |
07/10/2014 | US20140194536 Low-viscosity liquid crystal compound |
07/10/2014 | US20140194520 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
07/10/2014 | US20140194515 Use of a Composition Comprising an Antacid, a Mucolytic and a Gelling Agent in the Treatment of Cold |
07/10/2014 | US20140194510 Dispersions of rasagiline citrate |
07/10/2014 | US20140194456 Abuse-resistant controlled-release opioid dosage form |
07/10/2014 | US20140194453 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin |
07/10/2014 | US20140194357 Modified Relaxin Polypeptides and Their Uses |
07/10/2014 | US20140194356 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
07/10/2014 | US20140193908 Sequential antibody therapy |
07/10/2014 | US20140193513 Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof |
07/10/2014 | US20140193510 Polymer-Agent Conjugates, Particles, Compositions, and Related Methods of Use |
07/10/2014 | US20140193507 Preparation of injectable suspensions having improved injectability |
07/10/2014 | US20140193506 Protection against influenza infection by granulocyte-macrophage colony stimulating factor |
07/10/2014 | US20140193505 Biodegradable carrier with adjustable zeta potentials and particle sizes, method for making the same, and pharmaceutical composition comprising the same |
07/10/2014 | US20140193504 Polymer-drug systems |
07/10/2014 | US20140193501 Pulmonary Delivery in Treating Disorders of the Central Nervous System |
07/10/2014 | US20140193489 Dopamine Nanocapsules and Uses Thereof |
07/10/2014 | US20140193486 Sustained releasing composition via local injection for treating eye diseases |
07/10/2014 | US20140193481 Stabilised vaccine composition |
07/10/2014 | US20140193453 Immunomodulatory agent-polymeric compounds |
07/10/2014 | US20140193451 Immunogenic composition |
07/10/2014 | US20140193438 Enediyne compounds, conjugates thereof, and uses and methods therefor |
07/10/2014 | US20140193437 Hydrophilic self-immolative linkers and conjugates thereof |
07/10/2014 | US20140193436 Extracellular targeted drug conjugates |
07/10/2014 | US20140193414 Anti-her antibodies |
07/10/2014 | US20140193410 Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein |
07/10/2014 | US20140193409 Fusion proteins for delivery of gdnf to the cns |
07/10/2014 | US20140193365 Biodegradable Drug Delivery Composition |
07/10/2014 | US20140193359 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration |
07/10/2014 | US20140193358 Treating cancer stem cells using targeted cargo proteins |
07/10/2014 | US20140193347 Lipid depot formulations |
07/10/2014 | US20140193342 Enzyme directed assembly of particle theranostics |
07/10/2014 | US20140193335 Devices and methods for the treatment of cancer |